A commentary on ‘development and validation of safety and efficacy-associated risk calculator for hepatocellular carcinoma in the elderly after resection (searcher): a multi-instit...

por Huo, Teh-Ia, Ho, Shu-Yein, Liao, Jia-I
Publicado 2023

A commentary on ‘Nomograms for predicting the recurrence probability and recurrence-free survival in patients with hepatocellular carcinoma after conversion hepatectomy based on he...

por Huo, Teh-Ia, Ho, Shu-Yein, Liao, Jia-I
Publicado 2023

Comment on ‘Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion’

por Huo, Teh-Ia, Liu, Po-Hong, Hsu, Chia-Yang
Publicado 2017

Gastrointestinal and liver manifestations in patients with COVID-19

por Lee, I-Cheng, Huo, Teh-Ia, Huang, Yi-Hsiang
Publicado 2020

Role of dipeptidyl peptidase-4 inhibitors in patients with diabetes infected with coronavirus-19

por Chen, Chun-Fan, Chien, Chian-Hsu, Yang, Yi-Ping, Chou, Shih-Jie, Wang, Mong-Lien, Huo, The-Ia, Lin, Chih-Ching
Publicado 2020

CXCL9 Associated with Sustained Virological Response in Chronic Hepatitis B Patients Receiving Peginterferon Alfa-2a Therapy: A Pilot Study

por Lee, I-Cheng, Huang, Yi-Hsiang, Su, Chien-Wei, Wang, Yuan-Jen, Huo, Teh-Ia, Lee, Kuei-Chuan, Lin, Han-Chieh
Publicado 2013

Correlation and prognostic accuracy between noninvasive liver fibrosismarkers and portal pressure in cirrhosis: Role of ALBI score

por Hsieh, Yun-Cheng, Lee, Kuei-Chuan, Wang, Ying-Wen, Yang, Ying-Ying, Hou, Ming-Chih, Huo, Teh-Ia, Lin, Han-Chieh
Publicado 2018

Eritoran Attenuates Hepatic Inflammation and Fibrosis in Mice with Chronic Liver Injury

por Hsieh, Yun-Cheng, Lee, Kuei-Chuan, Wu, Pei-Shan, Huo, Teh-Ia, Huang, Yi-Hsiang, Hou, Ming-Chih, Lin, Han-Chieh
Publicado 2021

Comparison of Four Albumin-Based Liver Reserve Models (ALBI/EZ-ALBI/PALBI/PAL) against MELD for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization

por Ho, Shu-Yein, Liu, Po-Hong, Hsu, Chia-Yang, Huang, Yi-Hsiang, Liao, Jia-I, Su, Chien-Wei, Hou, Ming-Chih, Huo, Teh-Ia
Publicado 2023

Diabetes Diminishes the Portal-Systemic Collateral Vascular Response to Vasopressin via Vasopressin Receptor and G(α) Proteins Regulations in Cirrhotic Rats

por Lee, Jing-Yi, Huo, Teh-Ia, Wang, Sun-Sang, Huang, Hui-Chun, Lee, Fa-Yauh, Lin, Han-Chieh, Chuang, Chiao-Lin, Lee, Shou-Dong
Publicado 2013

Hepatocellular Carcinoma Patients With Performance Status 1 Deserve New Classification and Treatment Algorithm in the BCLC System

por Hsu, Chia-Yang, Liu, Po-Hong, Lee, Yun-Hsuan, Hsia, Cheng-Yuan, Huang, Yi-Hsiang, Chiou, Yi-You, Lin, Han-Chieh, Huo, Teh-Ia
Publicado 2015

Predictors of response to pegylated interferon in chronic hepatitis B: a real-world hospital-based analysis

por Wang, Yin-Chen, Yang, Sien-Sing, Su, Chien-Wei, Wang, Yuan-Jen, Lee, Kuei-Chuan, Huo, Teh-Ia, Lin, Han-Chieh, Huang, Yi-Hsiang
Publicado 2016

A New Tumor Burden Score and Albumin–Bilirubin Grade-Based Prognostic Model for Hepatocellular Carcinoma

por Ho, Shu-Yein, Liu, Po-Hong, Hsu, Chia-Yang, Huang, Yi-Hsiang, Liao, Jia-I, Su, Chien-Wei, Hou, Ming-Chih, Huo, Teh-Ia
Publicado 2022

Radiofrequency Ablation versus Transarterial Chemoembolization for Hepatocellular Carcinoma within Milan Criteria: Prognostic Role of Tumor Burden Score

por Ho, Shu-Yein, Liu, Po-Hong, Hsu, Chia-Yang, Huang, Yi-Hsiang, Liao, Jia-I, Su, Chien-Wei, Hou, Ming-Chih, Huo, Teh-Ia
Publicado 2022

Prognostic Prediction for Patients with Hepatocellular Carcinoma and Ascites: Role of Albumin-Bilirubin (ALBI) Grade and Easy (EZ)-ALBI Grade

por Liao, Jia-I, Ho, Shu-Yein, Liu, Po-Hong, Hsu, Chia-Yang, Huang, Yi-Hsiang, Su, Chien-Wei, Hou, Ming-Chih, Huo, Teh-Ia
Publicado 2023

The Role of Interferon-γ Inducible Protein-10 in a Mouse Model of Acute Liver Injury Post Induced Pluripotent Stem Cells Transplantation

por Chan, Che-Chang, Cheng, Ling-Yi, Lu, Jean, Huang, Yi-Hsiang, Chiou, Shih-Hwa, Tsai, Ping-Hsing, Huo, Teh-Ia, Lin, Han-Chieh, Lee, Fa-Yauh
Publicado 2012

Determinants of Survival After Sorafenib Failure in Patients With BCLC-C Hepatocellular Carcinoma in Real-World Practice

por Lee, I-Cheng, Chen, Yi-Tzen, Chao, Yee, Huo, Teh-Ia, Li, Chung-Pin, Su, Chien-Wei, Lin, Han-Chieh, Lee, Fa-Yauh, Huang, Yi-Hsiang
Publicado 2015

A New Treatment-integrated Prognostic Nomogram of the Barcelona Clinic Liver Cancer System for Hepatocellular Carcinoma

por Hsu, Chia-Yang, Liu, Po-Hong, Hsia, Cheng-Yuan, Lee, Yun-Hsuan, Nagaria, Teddy S., Lee, Rheun-Chuan, Ho, Shu-Yein, Hou, Ming-Chih, Huo, Teh-Ia
Publicado 2017

Risk of recurrence in chronic hepatitis B patients developing hepatocellular carcinoma with antiviral secondary prevention failure

por Lee, I-Cheng, Chau, Gar-Yang, Yeh, Yi-Chen, Chao, Yee, Huo, Teh-Ia, Su, Chien-Wei, Lin, Han-Chieh, Hou, Ming-Chih, Huang, Yi-Hsiang
Publicado 2017

Surgical resection versus transarterial chemoembolization for patients with hepatocellular carcinoma beyond Milan criteria: prognostic role of tumor burden score

por Ho, Shu-Yein, Liu, Po-Hong, Hsu, Chia-Yang, Huang, Yi-Hsiang, Lei, Hao-Jan, Liao, Jia-I, Su, Chien-Wei, Hou, Ming-Chih, Huo, Teh-Ia
Publicado 2023